Shareholders approve increase in authorized shares and reverse stock split range at special meeting

Proposal 5 – The issuance of 20% or more of the Company’s outstanding shares of Common Stock upon exercise of the common stock purchase warrants, dated January 23, 2024, issued to the Holders by the Company pursuant to certain securities purchase agreements, dated as of January 22, 2024, by and between the Company and each Holder, for the purposes of Nasdaq Rule 5635(d), was approved by the Company’s stockholders at the Special Meeting. The final voting results were as follows: For Against Abstain 8,394,637 3,002,112 249,282 There were 7,507,620 broker non-votes for Proposal 5.

Proposal 1 – The proposal to amend the Company’s certificate of incorporation (the “Certificate of Incorporation”) to authorize the Company’s board of the directors (the “Board”) to increase the Company’s share capital stock from 220,000,000 shares to 320,000,000 shares, of which 300,000,000 shares shall be Common Stock, was approved by the Company’s stockholders at the Special Meeting. The final voting results were as follows: For Against Abstain 24,266,573 3,497,426 108,889 There were 5,774,163 broker non-votes for Proposal 1.

Proposal 2 – The proposal to amend the Certificate of Incorporation to authorize the Board to effect a reverse stock split of all outstanding shares of Common Stock, by a ratio in the range of one-for-five to one-for-one hundred and fifty, to be determined in the Board’s sole discretion, was approved by the Company’s stockholders at the Special Meeting. The final voting results were as follows: For Against Abstain 28,051,938 5,488,074 107,039

Proposal 6 – The amendment to the Company’s 2018 Long-Term Stock Incentive Plan (the “LTIP”) to increase the annual share limit of Common Stock that may be issued only for the 2024 fiscal year under the LTIP from 8% of the shares of Common Stock outstanding to 15% of the shares of Common Stock outstanding, was approved by the Company’s stockholders at the Special Meeting. The final voting results were as follows: For Against Abstain 22,996,367 3,073,275 69,789 There were 7,507,620 broker non-votes for Proposal 6.

Proposal 4 – The issuance of 20% or more of the Company’s outstanding shares of Common Stock upon exercise of the common stock purchase warrants, issued to certain holders (“Holders”) of the Company’s Series B Convertible Preferred Stock purchase warrants issued on October 17, 2023, for purposes of Rule 5635(d) of The Nasdaq Stock Market LLC (“Nasdaq”), was approved by the Company’s stockholders at the Special Meeting. The final voting results were as follows: For Against Abstain 8,431,549 2,981,423 233,059 There were 7,507,620 broker non-votes for Proposal 4.